Innovator Liability: A Pandora’s Box For Pharma Cos.?
Law360 (April 2, 2018, 1:30 PM EDT) -- “[O]ur careful review of the federal regulatory scheme ... persuades us that a brand-name drug manufacturer has the duty ... to warn of the risks about which it knew or reasonably...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
